Join to View Full Profile
1500 E Medical Center Dr"# B1"Ann Arbor, MI 48109
Phone+1 734-647-8903
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ted Skolarus, MD is a board certified urologist in Ann Arbor, Michigan. He is currently licensed to practice medicine in Michigan, Indiana, and Illinois.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Urology, 2004 - 2008- Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year, 2003 - 2004
Wayne State University School of MedicineClass of 2003
Certifications & Licensure
IL State Medical License 2022 - 2026
IN State Medical License 2025 - 2025
MI State Medical License 2008 - 2024
American Board of Urology Urology
Publications & Presentations
PubMed
- Urologic oncology case volume among early career urologists: An analysis of certification data from the American board of urology between 2003 and 2019.Devki Shukla, Max J Hyman, Piyush K Agarwal, Sarah Faris, Ted A Skolarus
Urologic Oncology. 2025-05-01 - Multi-level Factors to Build Confidence and Support in Active Surveillance for Low-Risk Prostate Cancer: A Qualitative Study.Jason C Chen, Lalita Subramanian, Ted A Skolarus, Sarah T Hawley, Aaron Rankin
Journal of General Internal Medicine. 2025-04-01 - Furthering the Capacity of Urologists to Shape the Field of Dissemination and Implementation Science and Enhance Clinical Practice.Shellie D Ellis, Ted A Skolarus
The Journal of Urology. 2025-02-01
Press Mentions
Pre-Op Visits by Video? Most Surgeons Say No – but Open to Post-Op TelehealthJune 17th, 2024
Caring for Prostate Cancer SurvivorsDecember 19th, 2018- Primary Care Physician and Urologist Perspectives on Optimizing Active Surveillance for Low-Risk Prostate CancerMay 13th, 2025
Grant Support
- Refining castration use for recurrent prostate cancerUNIVERSITY OF MICHIGAN AT ANN ARBOR2020–2025
- De-implementation of low value castration for men with prostate cancerUNIVERSITY OF MICHIGAN AT ANN ARBOR2018–2024
